Table 1.
Baseline clinical characteristics
| Variable | Overall population (n = 155) | LAVI ≤ 34 m/m2 (n = 67) |
LAVI > 34 m/m2 (n = 88) |
p-value |
|---|---|---|---|---|
| Age, years | 72[63–80] | 68[61–76] | 78[67–83] | < 0.001 |
| Female, n(%) | 104(67) | 44(66) | 60(68) | 0.742 |
| BSA, m2 | 1.75[1.60–1.93] | 1.70[1.55–1.89] | 1.77[1.63–1.94] | 0.195 |
| Arterial hypertension, n(%) | 103(69) | 37(56) | 66(80) | 0.002 |
| Diabetes mellitus, n(%) | 44(30) | 22(33) | 22(27) | 0.390 |
| GFR < 30, ml/min/1.73 m2 | 17(12) | 6(10) | 11(14) | 0.422 |
| ß-blockers, n(%) | 73(50) | 24(37) | 49(60) | 0.006 |
| Calcium channel blockers, n(%) | 30(20) | 12(19) | 18(22) | 0.602 |
| ACEI/ARB, n(%) | 61(42) | 20(31) | 41(50) | 0.019 |
| Diuretics, n(%) | 57(40) | 16(25) | 41(49) | 0.002 |
| Anticoagulants, n(%) | 37(25) | 15(23) | 22(27) | 0.572 |
| Atrial fibrillation, n(%) | 48(32) | 22(33) | 26(31) | 0.794 |
| Stroke, n(%) | 36(24) | 15(23) | 21(26) | 0.685 |
Data are presented as mean ± SD if normally distributed or median (25th–75th percentile) if not normally distributed
ACEI angiotensin-converting enzyme inhibitor, ARB angiotensin receptor blocker, BSA body surface area, GFR glomerular filtration rate, LAVI left atrial volume index